An Investigation of the Mechanism of Action of Seretide in Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This study is investigating the possible mechanisms of action of an inhaled treatment
(Seretide), currently used worldwide in millions of patients with COPD (Chronic Obstructive
Pulmonary Disease) and how it improves the symptoms of these patients. Previous research has
failed to identify the mechanisms at play other than dilation of the airways. The research
community has long thought the mechanism to be immune based or anti inflammatory but despite
intensive research this has not yet been identified.
Phase:
Phase 4
Details
Lead Sponsor:
University of Southampton
Collaborator:
GlaxoSmithKline
Treatments:
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination